Clinical Drug Experience Knowledgebase

atezolizumab (Tecentriq) (2 trials)

bevacizumab (avastin) (2 trials)

carboplatin (paraplatin) (4 trials)

cediranib (1 trial)

cisplatin (platinol) (3 trials)

doxorubicin (Doxil) (2 trials)

gemcitabine (gemzar) (1 trial)

niraparib (zejula) (1 trial)

olaparib (lynparza) (3 trials)

paclitaxel (taxol) (5 trials)

topotecan (hycamtin) (1 trial)

catumaxomab (Removab) (1 trial)

dostarlimab (Jemperli) (1 trial)

letrozole (femara) (1 trial)

nintedanib (ofev) (1 trial)

palbociclib (ibrance) (1 trial)

pazopanib (votrient) (1 trial)